Loister Tablet contains Acotiamide 100mg, a prokinetic agent primarily indicated for the treatment of functional dyspepsia, including symptoms such as postprandial fullness, early satiety, and upper abdominal bloating. Acotiamide acts by enhancing gastric motility through the inhibition of acetylcholinesterase, thereby increasing acetylcholine levels in the enteric nervous system, which facilitates improved gastric emptying and accommodation. This mechanism helps alleviate discomfort associated with impaired gastric motility without significantly affecting gastric acid secretion. Loister is typically administered orally, with the recommended dosage and duration determined by a healthcare professional based on the patient’s clinical condition. It is generally well tolerated, with a low incidence of adverse effects; however, some patients may experience mild gastrointestinal disturbances such as nausea or diarrhea. Caution is advised in patients with known hypersensitivity to Acotiamide or any tablet components. Use during pregnancy and lactation should be considered only if the potential benefit justifies the potential risk to the fetus or infant. Loister Tablet should be used under medical supervision, and patients are advised to report any unusual symptoms promptly. It is important to adhere to prescribed dosages and complete the full course of therapy for optimal therapeutic outcomes.